These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 31275314

  • 1. Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood.
    Raeven RHM, van der Maas L, Pennings JLA, Fuursted K, Jørgensen CS, van Riet E, Metz B, Kersten GFA, Dalby T.
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [Abstract] [Full Text] [Related]

  • 2. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L, Rodeghiero C, Martini H, Litzroth A, Huygen K, Leroux-Roels G, Piérard D, Desombere I.
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [Abstract] [Full Text] [Related]

  • 3. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [Abstract] [Full Text] [Related]

  • 4. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group.
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [Abstract] [Full Text] [Related]

  • 5. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
    von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B.
    Eur J Pediatr; 2010 Sep; 169(9):1119-22. PubMed ID: 20373111
    [Abstract] [Full Text] [Related]

  • 6. Whooping cough surveillance in France in pediatric private practice in 2006-2015.
    Guiso N, Levy C, Romain O, Guillot S, Werner A, Rondeau MC, Béchet S, Cohen R.
    Vaccine; 2017 Oct 27; 35(45):6083-6088. PubMed ID: 28974408
    [Abstract] [Full Text] [Related]

  • 7. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Lima L, Molina MDGF, Pereira BS, Nadaf MLA, Nadaf MIV, Takano OA, Carneiro-Sampaio M, Palmeira P.
    Vaccine; 2019 May 01; 37(19):2569-2579. PubMed ID: 30955978
    [Abstract] [Full Text] [Related]

  • 8. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.
    Hallander H, Advani A, Alexander F, Gustafsson L, Ljungman M, Pratt C, Hall I, Gorringe AR.
    Clin Vaccine Immunol; 2014 Feb 01; 21(2):165-73. PubMed ID: 24307240
    [Abstract] [Full Text] [Related]

  • 9. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG, Ashworth LA, Miller E, Lambert HP.
    J Infect Dis; 1989 Nov 01; 160(5):838-45. PubMed ID: 2572651
    [Abstract] [Full Text] [Related]

  • 10. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q.
    Vaccine; 2012 Nov 06; 30(48):6897-902. PubMed ID: 22981763
    [Abstract] [Full Text] [Related]

  • 11. [Acellular pertussis vaccine].
    Zakharova NS, Britsina MV, Mertsalova NU, Bazhanova IG, Ozeretskovskaia MN, Zaĭtsev EM, Poddubikov AV, Semenov BF.
    Zh Mikrobiol Epidemiol Immunobiol; 2008 Nov 06; (1):35-41. PubMed ID: 18368750
    [Abstract] [Full Text] [Related]

  • 12. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
    Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.
    Vaccine; 2013 Aug 12; 31(36):3732-8. PubMed ID: 23742995
    [Abstract] [Full Text] [Related]

  • 13. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine].
    Zaĭtsev EM, Poddubikov AV, Britsina MV, Mertsalova NU, Ozeretskovskaia MN, Bazhanova IG, Plekhanova NG.
    Zh Mikrobiol Epidemiol Immunobiol; 2014 Aug 12; (1):20-4. PubMed ID: 24738289
    [Abstract] [Full Text] [Related]

  • 14. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK, Litt DJ, Duncan J, Vaghji L, Warrener L, Samuel D, Andrews N, Harnden A, Harrison TG.
    J Med Microbiol; 2013 Sep 12; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [Abstract] [Full Text] [Related]

  • 15. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U, Cherry JD, Stehr K.
    Clin Infect Dis; 2004 Feb 15; 38(4):591-4. PubMed ID: 14765356
    [Abstract] [Full Text] [Related]

  • 16. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 15; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 17. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985 Mar 15; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 18. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.
    Hendrikx LH, Schure RM, Oztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM.
    Vaccine; 2011 Sep 16; 29(40):6874-80. PubMed ID: 21803088
    [Abstract] [Full Text] [Related]

  • 19. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.
    Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA.
    Clin Vaccine Immunol; 2011 Jun 16; 18(6):954-62. PubMed ID: 21508166
    [Abstract] [Full Text] [Related]

  • 20. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.
    Pediatrics; 1997 Nov 16; 100(5):772-88. PubMed ID: 9346976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.